1. A novel anti-androgen candidate galeterone acts by targeting USP12, a deubiquitinating enzyme that controls prostate cancer growth and survival. (December 2016) Authors: McClurg, U.; Dransfield, D.; Namdev, N.; Jacoby, D.; Chit, N.; Nakjang, S.; Edwards, J.; McCracken, S.; Robson, C. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Intracerebroventricular cerliponase alfa for children with CLN2 disease: Interim results from an ongoing phase 2 extension study. (June 2017) Authors: Schulz, A.; Specchio, N.; Gissen, P.; de los Reyes, E.; Cahan, H.; Slasor, P.; Ajayi, T.; Jacoby, D. Journal: European journal of paediatric neurology Issue: Volume 21(2017)Supplement 1 Page Start: e21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗